Biblio
Export 725 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is Z [Clear All Filters]
“Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
, “Association of Plastic Exposure with Cognitive Function Among Chinese Older Adults.”, J Alzheimers Dis, vol. 101, no. 3, pp. 1015-1025, 2024.
, “Association of Statin Use with Dementia Risk Among Older Adults in Japan: A Nested Case-Control Study Using the LIFE Study.”, J Alzheimers Dis, vol. 100, no. 3, pp. 987-998, 2024.
, “Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.”, J Alzheimers Dis, vol. 98, no. 2, pp. 373-385, 2024.
, “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
, “Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases.”, J Alzheimers Dis, vol. 100, no. s1, pp. S93-S101, 2024.
, “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
, “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
, “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
, “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
, “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
, “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
, “Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 100, no. 1, pp. 279-296, 2024.
, “Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.”, J Alzheimers Dis, vol. 97, no. 2, pp. 777-790, 2024.
, “The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.”, J Alzheimers Dis, vol. 100, no. 1, pp. 77-85, 2024.
, “Influence of genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.”, J Alzheimers Dis, vol. 102, no. 1, pp. 162-172, 2024.
, “An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.”, J Alzheimers Dis, vol. 98, no. 2, pp. 601-618, 2024.
, “Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1861-1875, 2024.
, “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
, “A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.”, J Alzheimers Dis, vol. 101, no. 3, pp. 923-936, 2024.
, “O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1051-1068, 2024.
, “Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.”, J Alzheimers Dis, vol. 100, no. s1, pp. S197-S209, 2024.
, “Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1173-1186, 2024.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
, “Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
,